{"id":13885,"date":"2025-05-27T12:00:05","date_gmt":"2025-05-27T10:00:05","guid":{"rendered":"https:\/\/maat.swebwp.oci.eu\/?page_id=13885"},"modified":"2026-02-02T15:19:44","modified_gmt":"2026-02-02T13:19:44","slug":"phase-3","status":"publish","type":"page","link":"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/","title":{"rendered":"Phase 3"},"content":{"rendered":"[vc_row type=\u00a0\u00bbfull_width_background\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb bg_image=\u00a0\u00bb760&Prime; bg_position=\u00a0\u00bbcenter center\u00a0\u00bb background_image_loading=\u00a0\u00bbdefault\u00a0\u00bb bg_repeat=\u00a0\u00bbno-repeat\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb top_padding=\u00a0\u00bb10%\u00a0\u00bb bottom_padding=\u00a0\u00bb14%\u00a0\u00bb text_color=\u00a0\u00bblight\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb enable_gradient=\u00a0\u00bbtrue\u00a0\u00bb color_overlay=\u00a0\u00bbrgba(91,192,204,0.94)\u00a0\u00bb color_overlay_2=\u00a0\u00bb#014f90&Prime; overlay_strength=\u00a0\u00bb0.95&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb enable_shape_divider=\u00a0\u00bbtrue\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb shape_divider_height=\u00a0\u00bb190&Prime; bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb parallax_bg=\u00a0\u00bbtrue\u00a0\u00bb parallax_bg_speed=\u00a0\u00bbfast\u00a0\u00bb shape_type=\u00a0\u00bbcurve\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/6&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb centered_text=\u00a0\u00bbtrue\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb2\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][split_line_heading animation_type=\u00a0\u00bbdefault\u00a0\u00bb]\n<h1>Xervyteg<sup>\u00ae<\/sup> (MaaT013) : R\u00e9sultats Positifs de la Phase 3 dans la maladie aigu\u00eb du greffon contre l&rsquo;h\u00f4te<\/h1>\n[\/split_line_heading][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/6&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb left_padding_desktop=\u00a0\u00bb22&Prime; text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbcenter\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb color_overlay=\u00a0\u00bbrgba(91,192,204,0.4)\u00a0\u00bb color_overlay_2=\u00a0\u00bbrgba(91,192,204,0.4)\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb shape_type=\u00a0\u00bb\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][page_submenu alignment=\u00a0\u00bbcenter\u00a0\u00bb sticky=\u00a0\u00bbtrue\u00a0\u00bb link_color=\u00a0\u00bb#014f90&Prime;][page_link link_url=\u00a0\u00bb#results\u00a0\u00bb title=\u00a0\u00bbR\u00e9sultats\u00a0\u00bb id=\u00a0\u00bb1770038358099-5&Prime; tab_id=\u00a0\u00bb1770038358100-8&Prime;] [\/page_link][page_link link_url=\u00a0\u00bb#design\u00a0\u00bb title=\u00a0\u00bbDesign de l&rsquo;\u00e9tude\u00a0\u00bb id=\u00a0\u00bb1770038358140-3&Prime; tab_id=\u00a0\u00bb1770038358141-8&Prime;] [\/page_link][page_link link_new_tab=\u00a0\u00bbtrue\u00a0\u00bb title=\u00a0\u00bbSoumission aupr\u00e8s de l&rsquo;EMA\u00a0\u00bb id=\u00a0\u00bb1770038358154-10&Prime; tab_id=\u00a0\u00bb1770038358155-10&Prime; link_url=\u00a0\u00bbhttps:\/\/maat.swebwp.oci.eu\/fr\/soumission-ema\/\u00a0\u00bb][\/page_link][\/page_submenu][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb left_padding_desktop=\u00a0\u00bb22&Prime; text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bb10px\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb disable_element=\u00a0\u00bbyes\u00a0\u00bb color_overlay=\u00a0\u00bb#00b4f5&Prime; overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbzoom-out\u00a0\u00bb shape_type=\u00a0\u00bbstraight_section\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb2\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][toggles style=\u00a0\u00bbminimal\u00a0\u00bb][toggle color=\u00a0\u00bbExtra-Color-1&Prime; title=\u00a0\u00bbStudy Design\u00a0\u00bb][image_with_animation image_url=\u00a0\u00bb13892&Prime; animation=\u00a0\u00bbFade In\u00a0\u00bb hover_animation=\u00a0\u00bbnone\u00a0\u00bb alignment=\u00a0\u00bb\u00a0\u00bb border_radius=\u00a0\u00bbnone\u00a0\u00bb box_shadow=\u00a0\u00bbnone\u00a0\u00bb image_loading=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb100%\u00a0\u00bb max_width_mobile=\u00a0\u00bbdefault\u00a0\u00bb][vc_column_text]\n<p style=\"text-align: left;\">The study was conducted in <strong>6 European countries<\/strong> (Austria, Belgium, France,Germany, Italy and Spain) <strong>accross 50 sites.<\/strong><\/p>\n[\/vc_column_text][nectar_btn size=\u00a0\u00bblarge\u00a0\u00bb button_style=\u00a0\u00bbregular\u00a0\u00bb button_color_2=\u00a0\u00bbAccent-Color\u00a0\u00bb icon_family=\u00a0\u00bbnone\u00a0\u00bb text=\u00a0\u00bbRead more: Clinical Trial.Gov\u00a0\u00bb margin_right=\u00a0\u00bb100&Prime;][\/toggle][\/toggles][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][nectar_btn size=\u00a0\u00bbjumbo\u00a0\u00bb button_style=\u00a0\u00bbregular\u00a0\u00bb button_color_2=\u00a0\u00bbExtra-Color-1&Prime; icon_family=\u00a0\u00bbnone\u00a0\u00bb text=\u00a0\u00bbSee the press release\u00a0\u00bb margin_top=\u00a0\u00bb10&Prime;][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb bg_color=\u00a0\u00bb#ffffff\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb left_padding_desktop=\u00a0\u00bb22&Prime; text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bb10px\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb id=\u00a0\u00bbdesign\u00a0\u00bb color_overlay=\u00a0\u00bb#ffffff\u00a0\u00bb color_overlay_2=\u00a0\u00bb#ffffff\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbzoom-out\u00a0\u00bb shape_type=\u00a0\u00bbstraight_section\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][toggles style=\u00a0\u00bbminimal\u00a0\u00bb][toggle color=\u00a0\u00bbExtra-Color-1&Prime; title=\u00a0\u00bbDesign de l&rsquo;\u00e9tude\u00a0\u00bb][image_with_animation image_url=\u00a0\u00bb14069&Prime; animation=\u00a0\u00bbFade In\u00a0\u00bb hover_animation=\u00a0\u00bbnone\u00a0\u00bb alignment=\u00a0\u00bbcenter\u00a0\u00bb border_radius=\u00a0\u00bbnone\u00a0\u00bb box_shadow=\u00a0\u00bbnone\u00a0\u00bb image_loading=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb100%\u00a0\u00bb max_width_mobile=\u00a0\u00bbdefault\u00a0\u00bb][vc_column_text]\n<h4>Crit\u00e8res d&rsquo;inclusion :<\/h4>\n<ul>\n<li>\u00c2ge \u2265 18 ans<\/li>\n<li>Allo-GCSH avec tout type de donneur, source de cellules souches, prophylaxie de la GvH ou sch\u00e9ma de conditionnement<\/li>\n<li>Patients d\u00e9veloppant un \u00e9pisode d&rsquo;aGvH avec atteinte gastro-intestinale selon les directives MAGIC (grades II \u00e0 IV), avec ou sans atteinte d&rsquo;autres organes (Harris et al., 2016)<\/li>\n<li>Patients r\u00e9sistants aux cortico\u00efdes ET soit r\u00e9sistants \u00e0 OU intol\u00e9rants au ruxolitinib (patients intol\u00e9rants : ayant pr\u00e9sent\u00e9 un \u00e9v\u00e9nement ind\u00e9sirable de grade 3 ou plus, apparu sous traitement et attribu\u00e9 au ruxolitinib, qui n&rsquo;a pas \u00e9t\u00e9 r\u00e9solu dans les 7 jours suivant l&rsquo;arr\u00eat du ruxolitinib). Le diagnostic doit \u00eatre confirm\u00e9 dans les 48 heures pr\u00e9c\u00e9dant le d\u00e9but du pr\u00e9-traitement de l&rsquo;\u00e9tude.<\/li>\n<\/ul>\n[\/vc_column_text][vc_column_text]\n<p style=\"text-align: left;\">L&rsquo;\u00e9tude a \u00e9t\u00e9 men\u00e9e dans <strong>6 pays europ\u00e9ens <\/strong>(Autriche, Belgique, France, Allemagne, Italie et Espagne) <strong>sur 50 sites.<\/strong><\/p>\n[\/vc_column_text][nectar_btn size=\u00a0\u00bblarge\u00a0\u00bb button_style=\u00a0\u00bbregular\u00a0\u00bb button_color_2=\u00a0\u00bbAccent-Color\u00a0\u00bb icon_family=\u00a0\u00bbnone\u00a0\u00bb text=\u00a0\u00bbRead more: Clinical Trial.Gov\u00a0\u00bb margin_right=\u00a0\u00bb100&Prime; url=\u00a0\u00bbhttps:\/\/clinicaltrials.gov\/study\/NCT04769895&Prime;][\/toggle][\/toggles][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb id=\u00a0\u00bbresults\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb shape_type=\u00a0\u00bb\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text el_class=\u00a0\u00bbPhase3Title\u00a0\u00bb]\n<h2>ARES : Forte r\u00e9ponse \u00e0 Xervyteg<sup>\u00ae<\/sup> (MaaT013) dans l&rsquo;aGvH apr\u00e8s un \u00e9chec des traitements aux cortico\u00efdes et au ruxolitinib<\/h2>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb shape_type=\u00a0\u00bb\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/2&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][image_with_animation image_url=\u00a0\u00bb14185&Prime; animation=\u00a0\u00bbFade In\u00a0\u00bb hover_animation=\u00a0\u00bbnone\u00a0\u00bb alignment=\u00a0\u00bb\u00a0\u00bb border_radius=\u00a0\u00bbnone\u00a0\u00bb box_shadow=\u00a0\u00bbnone\u00a0\u00bb image_loading=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb100%\u00a0\u00bb max_width_mobile=\u00a0\u00bbdefault\u00a0\u00bb][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/2&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text]\n<ul>\n<li>\n<h4><strong>62 % de GI-ORR avec des taux \u00e9lev\u00e9s de r\u00e9ponse compl\u00e8te et de tr\u00e8s bonne r\u00e9ponse partielle.<\/strong><\/h4>\n<\/li>\n<li>\n<h4><strong>64% de ORR indiquant une efficacit\u00e9 au-del\u00e0 du tractus gastro-intestinal.<\/strong><\/h4>\n<\/li>\n<\/ul>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][divider line_type=\u00a0\u00bbFull Width Line\u00a0\u00bb line_thickness=\u00a0\u00bb1&Prime; divider_color=\u00a0\u00bbdefault\u00a0\u00bb][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb shape_type=\u00a0\u00bb\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/2&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][image_with_animation image_url=\u00a0\u00bb14187&Prime; animation=\u00a0\u00bbFade In\u00a0\u00bb hover_animation=\u00a0\u00bbnone\u00a0\u00bb alignment=\u00a0\u00bb\u00a0\u00bb border_radius=\u00a0\u00bbnone\u00a0\u00bb box_shadow=\u00a0\u00bbnone\u00a0\u00bb image_loading=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb100%\u00a0\u00bb max_width_mobile=\u00a0\u00bbdefault\u00a0\u00bb][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/2&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text]\n<ul>\n<li>\n<h4><strong>La probabilit\u00e9 de survie globale \u00e0 12 mois \u00e9tait de 54% (m\u00e9diane de survie non atteinte).<\/strong><\/h4>\n<\/li>\n<li>\n<h4><strong>La probabilit\u00e9 de survie globale \u00e0 12 mois des patients r\u00e9pondeurs au 28<sup>\u00e8me<\/sup>\u00a0jour \u00e9tait significativement plus \u00e9lev\u00e9e que celle des non-r\u00e9pondeurs (respectivement 67% vs 28%, p &lt;0,0001), soulignant le b\u00e9n\u00e9fice clinique significatif de MaaT013 en termes de survie dans les cas de GI-aGvH r\u00e9fractaires.<\/strong><\/h4>\n<\/li>\n<\/ul>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][divider line_type=\u00a0\u00bbFull Width Line\u00a0\u00bb line_thickness=\u00a0\u00bb1&Prime; divider_color=\u00a0\u00bbdefault\u00a0\u00bb][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb shape_type=\u00a0\u00bb\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/2&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][image_with_animation image_url=\u00a0\u00bb14189&Prime; animation=\u00a0\u00bbFade In\u00a0\u00bb hover_animation=\u00a0\u00bbnone\u00a0\u00bb alignment=\u00a0\u00bb\u00a0\u00bb border_radius=\u00a0\u00bbnone\u00a0\u00bb box_shadow=\u00a0\u00bbnone\u00a0\u00bb image_loading=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb100%\u00a0\u00bb max_width_mobile=\u00a0\u00bbdefault\u00a0\u00bb][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/2&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text]\n<ul>\n<li>\n<h4><strong>Survie prolong\u00e9e associ\u00e9e \u00e0 la r\u00e9ponse<\/strong><\/h4>\n<\/li>\n<li>\n<h4><strong>Probabilit\u00e9 de survie \u00e0 1 an de 54%, contre 15% apr\u00e8s le meilleur traitement disponible (Abedin et al., 2021)<\/strong><\/h4>\n<\/li>\n<\/ul>\n[\/vc_column_text][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb bottom_padding=\u00a0\u00bb2%\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb id=\u00a0\u00bbresults\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb shape_type=\u00a0\u00bb\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text]\n<h4>Les patients recrut\u00e9s continueront \u00e0 \u00eatre suivis pour des crit\u00e8res d&rsquo;\u00e9valuation secondaires et exploratoires pendant toute la dur\u00e9e de l&rsquo;\u00e9tude.<\/h4>\n[\/vc_column_text][nectar_btn size=\u00a0\u00bbjumbo\u00a0\u00bb button_style=\u00a0\u00bbregular\u00a0\u00bb button_color_2=\u00a0\u00bbExtra-Color-1&Prime; icon_family=\u00a0\u00bbnone\u00a0\u00bb text=\u00a0\u00bbLire le communiqu\u00e9 de presse\u00a0\u00bb margin_top=\u00a0\u00bb10&Prime; url=\u00a0\u00bbhttps:\/\/maat.swebwp.oci.eu\/fr\/8-janvier-2025-maat-pharma-annonce-des-resultats-positifs-pour-letude-pivotale-de-phase-3-ares-evaluant-maat013-dans-la-maladie-aigue-du-greffon-contre-lhote\/\u00a0\u00bb][vc_row_inner equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb right_padding_desktop=\u00a0\u00bb30&Prime; text_align=\u00a0\u00bbleft\u00a0\u00bb el_id=\u00a0\u00bbvalues\u00a0\u00bb][vc_column_inner column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb bottom_margin=\u00a0\u00bb20&Prime; column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb2\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][divider line_type=\u00a0\u00bbNo Line\u00a0\u00bb][divider line_type=\u00a0\u00bbNo Line\u00a0\u00bb][vc_column_text]\n<blockquote><p><em><strong>\u201c<\/strong> <strong>Les r\u00e9sultats impressionnants de l&rsquo;essai de phase 3 de Xervyteg<sup>\u00ae<\/sup> (MaaT013) marquent un pas en avant dans le traitement de la GI-aGvHD r\u00e9fractaire. Avec un GI-ORR de 62% au 28\u00e8me jour et une probabilit\u00e9 de survie \u00e0 12 mois estim\u00e9e \u00e0 54%, ces r\u00e9sultats soulignent le r\u00f4le curatif des th\u00e9rapies bas\u00e9es sur le microbiote dans l&rsquo;obtention de r\u00e9ponses durables conduisant \u00e0 une survie prolong\u00e9e. Alors que Xervyteg<sup>\u00ae<\/sup> (MaaT013) est de plus en plus adopt\u00e9 en Europe, il pourrait red\u00e9finir les normes de soins pour les patients confront\u00e9s \u00e0 cette complication potentiellement mortelle. \u201d<\/strong><\/em><\/p>\n<p>Dr. Malard, professeur d&rsquo;h\u00e9matologie \u00e0 l&rsquo;h\u00f4pital Saint-Antoine et \u00e0 Sorbonne Universit\u00e9, investigateur principal de l&rsquo;essai de Phase 3 ARES<\/p><\/blockquote>\n[\/vc_column_text][\/vc_column_inner][vc_column_inner column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][image_with_animation image_url=\u00a0\u00bb13917&Prime; animation=\u00a0\u00bbGrow In\u00a0\u00bb hover_animation=\u00a0\u00bbnone\u00a0\u00bb alignment=\u00a0\u00bbright\u00a0\u00bb border_radius=\u00a0\u00bb15px\u00a0\u00bb box_shadow=\u00a0\u00bbnone\u00a0\u00bb image_loading=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb75%\u00a0\u00bb max_width_mobile=\u00a0\u00bbdefault\u00a0\u00bb delay=\u00a0\u00bb150&Prime;][\/vc_column_inner][\/vc_row_inner][toggles style=\u00a0\u00bbminimal\u00a0\u00bb][toggle color=\u00a0\u00bbDefault\u00a0\u00bb title=\u00a0\u00bbD\u00e9finitions\u00a0\u00bb][vc_column_text]\n<ul>\n<li><sup>1 <\/sup>Dans l&rsquo;\u00e9tude ARES, la SR-GI-aGvHD est d\u00e9finie comme les patients r\u00e9sistants aux cortico\u00efdes ET r\u00e9sistants OU intol\u00e9rants au ruxolitinib (patients intol\u00e9rants : ayant pr\u00e9sent\u00e9 un effet ind\u00e9sirable de grade 3 ou plus, apparu sous traitement et attribu\u00e9 au ruxolitinib, qui ne s&rsquo;est pas r\u00e9solu dans les 7 jours suivant l&rsquo;arr\u00eat du ruxolitinib). Les cas de SR-aGvHD incluent les patients ayant re\u00e7u une forte dose de cortico\u00efdes syst\u00e9miques (m\u00e9thylprednisolone 2 mg\/kg\/jour &#8211; ou une dose \u00e9quivalente de prednisone 2,5 mg\/kg\/jour), administr\u00e9e seule ou en association avec un inhibiteur de la calcineurine ou un inhibiteur de mTOR, et qui ont pr\u00e9sent\u00e9 l&rsquo;une ou l&rsquo;autre des caract\u00e9ristiques suivantes :\n<ul>\n<li>Absence d&rsquo;am\u00e9lioration (c&rsquo;est-\u00e0-dire pas de diminution du stade dans au moins 1 organe impliqu\u00e9) apr\u00e8s \u2265 5 jours de traitement par cortico\u00efdes \u00e0 une dose \u00e9quivalente \u00e0 2 mg\/kg\/j de m\u00e9thylprednisolone, <strong>ou<\/strong><\/li>\n<li>Progression (c&rsquo;est-\u00e0-dire augmentation dans un organe ou\u00a0 atteinte d&rsquo;un nouvel organe) apr\u00e8s \u2265 3 jours de traitement par cortico\u00efdes \u00e0 une dose \u00e9quivalente \u00e0 2 mg\/kg\/j de m\u00e9thylprednisolone, <strong>ou<\/strong><\/li>\n<li>Les patients trait\u00e9s par 1 mg\/kg\/j de cortico\u00efdes parce que le m\u00e9decin a estim\u00e9 qu&rsquo;ils ne tol\u00e9reraient pas 2 mg\/kg\/j et qui correspondent \u00e0 la d\u00e9finition des patients SR, <strong>ou<\/strong><\/li>\n<li>Les patients qui ont commenc\u00e9 un traitement par cortico\u00efdes \u00e0 une dose plus faible (au moins 1 mg\/kg\/j d&rsquo;\u00e9quivalent m\u00e9thylprednisolone) mais qui d\u00e9veloppent des nouveaux sympt\u00f4mes dans un autre organe, <strong>ou<\/strong><\/li>\n<li>Les patients qui ne peuvent pas tol\u00e9rer la diminution progressive des cortico\u00efdes, c&rsquo;est-\u00e0-dire qui commencent les cortico\u00efdes \u00e0 2,0 mg\/kg\/j, montrent une r\u00e9ponse, mais progressent avant qu&rsquo;une diminution de 50 % de la dose initiale de cortico\u00efdes ne soit atteinte.<\/li>\n<\/ul>\n<\/li>\n<li><u> <\/u>La r\u00e9sistance au ruxolitinib est d\u00e9finie comme l&rsquo;un des \u00e9l\u00e9ments suivants <u><a href=\"https:\/\/ashpublications.org\/blood\/article\/136\/17\/1903\/461710\/Refractory-acute-graft-versus-host-disease-a-new\">(Mohty M. 2020) <\/a><\/u>:\n<ul>\n<li>Progression de la GvHD par rapport \u00e0 l&rsquo;\u00e9tat initial apr\u00e8s au moins 5 jours de traitement par ruxolitinib, bas\u00e9e soit sur une augmentation objective du stade\/grade, soit sur une atteinte d&rsquo;un nouvel organe, <strong>ou<\/strong><\/li>\n<li>Absence d&rsquo;am\u00e9lioration de la GvHD (au moins une r\u00e9ponse partielle) par rapport \u00e0 l&rsquo;\u00e9tat initial, apr\u00e8s au moins 14 jours de traitement par ruxolitinib, <strong>ou<\/strong><\/li>\n<li>Perte de r\u00e9ponse, d\u00e9finie comme une aggravation objective de la GvHD d\u00e9termin\u00e9e par une augmentation du stade, du grade ou l&rsquo;atteinte d&rsquo;un nouvel organe, \u00e0 tout moment apr\u00e8s une am\u00e9lioration initiale, <strong>ou<\/strong><\/li>\n<li>Absence de r\u00e9ponse compl\u00e8te ou de tr\u00e8s bonne r\u00e9ponse partielle au 28\u00e8me jour apr\u00e8s le d\u00e9but du traitement avec ruxolitinib.<\/li>\n<\/ul>\n<\/li>\n<li>L&rsquo;intol\u00e9rance au ruxolitinib est d\u00e9finie comme des manifestations de GvHD persistant sans am\u00e9lioration chez les patients ayant pr\u00e9sent\u00e9 un effet ind\u00e9sirable de grade 3 ou plus, apparu sous traitement et attribu\u00e9 au ruxolitinib, qui ne s&rsquo;est pas r\u00e9solu dans les 7 jours suivant l&rsquo;arr\u00eat du ruxolitinib.<\/li>\n<li>aGVHD : maladie aigu\u00eb du greffon contre l&rsquo;h\u00f4te<\/li>\n<li>GI : gastro-intestinal<\/li>\n<li>MAGIC : Consortium international Mount Sinai pour la GVHD aigu\u00eb<\/li>\n<li>ORR : taux de r\u00e9ponse global<\/li>\n<li>SR : r\u00e9fractaire aux st\u00e9ro\u00efdes<\/li>\n<li>D : Jour<\/li>\n<li>M : Mois<\/li>\n<\/ul>\n[\/vc_column_text][\/toggle][\/toggles][\/vc_column][\/vc_row][vc_row type=\u00a0\u00bbin_container\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb bottom_padding=\u00a0\u00bb6%\u00a0\u00bb text_color=\u00a0\u00bbdark\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb id=\u00a0\u00bbresults\u00a0\u00bb disable_element=\u00a0\u00bbyes\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb shape_type=\u00a0\u00bb\u00a0\u00bb][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][image_with_animation image_url=\u00a0\u00bb14114&Prime; animation=\u00a0\u00bbFade In\u00a0\u00bb hover_animation=\u00a0\u00bbnone\u00a0\u00bb alignment=\u00a0\u00bb\u00a0\u00bb border_radius=\u00a0\u00bbnone\u00a0\u00bb box_shadow=\u00a0\u00bbnone\u00a0\u00bb image_loading=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb100%\u00a0\u00bb max_width_mobile=\u00a0\u00bbdefault\u00a0\u00bb][vc_row_inner equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb right_padding_desktop=\u00a0\u00bb30&Prime; text_align=\u00a0\u00bbleft\u00a0\u00bb el_id=\u00a0\u00bbresults\u00a0\u00bb][vc_column_inner column_padding=\u00a0\u00bbpadding-4-percent\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bbright\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/2&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text]\n<ul>\n<li>62 % de GI-ORR avec des taux \u00e9lev\u00e9s de r\u00e9ponse compl\u00e8te et de tr\u00e8s bonne r\u00e9ponse partielle.<\/li>\n<li>64% de ORR indiquant une efficacit\u00e9 au-del\u00e0 du tractus gastro-intestinal.<\/li>\n<\/ul>\n[\/vc_column_text][\/vc_column_inner][vc_column_inner column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb bottom_margin=\u00a0\u00bb20&Prime; column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/2&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text]\n<ul>\n<li>Survie prolong\u00e9e associ\u00e9e \u00e0 la r\u00e9ponse<\/li>\n<li>Probabilit\u00e9 de survie \u00e0 1 an de 54%, contre 15% apr\u00e8s le meilleur traitement disponible (Abedin et al., 2021).<\/li>\n<\/ul>\n[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_column_text]\n<h4>Les patients recrut\u00e9s continueront \u00e0 \u00eatre suivis pour des crit\u00e8res d&rsquo;\u00e9valuation secondaires et exploratoires pendant toute la dur\u00e9e de l&rsquo;\u00e9tude.<\/h4>\n[\/vc_column_text][vc_row_inner equal_height=\u00a0\u00bbyes\u00a0\u00bb content_placement=\u00a0\u00bbmiddle\u00a0\u00bb disable_element=\u00a0\u00bbyes\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb right_padding_desktop=\u00a0\u00bb30&Prime; text_align=\u00a0\u00bbleft\u00a0\u00bb el_id=\u00a0\u00bbvalues\u00a0\u00bb][vc_column_inner column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb bottom_margin=\u00a0\u00bb20&Prime; column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb2\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][vc_column_text]\n<blockquote>\n<h3><em>\u201cfere tumultuosum, in eius perniciem conspiraret, solisque scholis iussit essefere tumultuosum, in eius perniciem conspiraret, solisque scholis iussit essefere tumultuosum, in eius perniciem conspiraret, solisque scholis iussit esse\u201d<\/em><\/h3>\n<p>Prof. Malard, MD, hematology professor at Saint-Antoine Hospital and Sorbonne University, lead investigator for the Phase 3 ARES trial<\/p><\/blockquote>\n[\/vc_column_text][\/vc_column_inner][vc_column_inner column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/3&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][image_with_animation image_url=\u00a0\u00bb13917&Prime; animation=\u00a0\u00bbGrow In\u00a0\u00bb hover_animation=\u00a0\u00bbnone\u00a0\u00bb alignment=\u00a0\u00bbright\u00a0\u00bb border_radius=\u00a0\u00bb15px\u00a0\u00bb box_shadow=\u00a0\u00bbnone\u00a0\u00bb image_loading=\u00a0\u00bbdefault\u00a0\u00bb max_width=\u00a0\u00bb50%\u00a0\u00bb max_width_mobile=\u00a0\u00bbdefault\u00a0\u00bb][\/vc_column_inner][\/vc_row_inner][nectar_btn size=\u00a0\u00bbjumbo\u00a0\u00bb button_style=\u00a0\u00bbregular\u00a0\u00bb button_color_2=\u00a0\u00bbExtra-Color-1&Prime; icon_family=\u00a0\u00bbnone\u00a0\u00bb text=\u00a0\u00bbLire le communiqu\u00e9 de presse\u00a0\u00bb margin_top=\u00a0\u00bb10&Prime; url=\u00a0\u00bbhttps:\/\/maat.swebwp.oci.eu\/fr\/8-janvier-2025-maat-pharma-annonce-des-resultats-positifs-pour-letude-pivotale-de-phase-3-ares-evaluant-maat013-dans-la-maladie-aigue-du-greffon-contre-lhote\/\u00a0\u00bb][toggles style=\u00a0\u00bbminimal\u00a0\u00bb][toggle color=\u00a0\u00bbDefault\u00a0\u00bb title=\u00a0\u00bbD\u00e9finitions\u00a0\u00bb][vc_column_text]\n<ul>\n<li><sup>1 <\/sup>Dans l&rsquo;\u00e9tude ARES, la SR-GI-aGvHD est d\u00e9finie comme les patients r\u00e9sistants aux cortico\u00efdes ET r\u00e9sistants OU intol\u00e9rants au ruxolitinib (patients intol\u00e9rants : ayant pr\u00e9sent\u00e9 un effet ind\u00e9sirable de grade 3 ou plus, apparu sous traitement et attribu\u00e9 au ruxolitinib, qui ne s&rsquo;est pas r\u00e9solu dans les 7 jours suivant l&rsquo;arr\u00eat du ruxolitinib). Les cas de SR-aGvHD incluent les patients ayant re\u00e7u une forte dose de cortico\u00efdes syst\u00e9miques (m\u00e9thylprednisolone 2 mg\/kg\/jour &#8211; ou une dose \u00e9quivalente de prednisone 2,5 mg\/kg\/jour), administr\u00e9e seule ou en association avec un inhibiteur de la calcineurine ou un inhibiteur de mTOR, et qui ont pr\u00e9sent\u00e9 l&rsquo;une ou l&rsquo;autre des caract\u00e9ristiques suivantes :\n<ul>\n<li>Absence d&rsquo;am\u00e9lioration (c&rsquo;est-\u00e0-dire pas de diminution du stade dans au moins 1 organe impliqu\u00e9) apr\u00e8s \u2265 5 jours de traitement par cortico\u00efdes \u00e0 une dose \u00e9quivalente \u00e0 2 mg\/kg\/j de m\u00e9thylprednisolone, <strong>ou<\/strong><\/li>\n<li>Progression (c&rsquo;est-\u00e0-dire augmentation dans un organe ou\u00a0 atteinte d&rsquo;un nouvel organe) apr\u00e8s \u2265 3 jours de traitement par cortico\u00efdes \u00e0 une dose \u00e9quivalente \u00e0 2 mg\/kg\/j de m\u00e9thylprednisolone, <strong>ou<\/strong><\/li>\n<li>Les patients trait\u00e9s par 1 mg\/kg\/j de cortico\u00efdes parce que le m\u00e9decin a estim\u00e9 qu&rsquo;ils ne tol\u00e9reraient pas 2 mg\/kg\/j et qui correspondent \u00e0 la d\u00e9finition des patients SR, <strong>ou<\/strong><\/li>\n<li>Les patients qui ont commenc\u00e9 un traitement par cortico\u00efdes \u00e0 une dose plus faible (au moins 1 mg\/kg\/j d&rsquo;\u00e9quivalent m\u00e9thylprednisolone) mais qui d\u00e9veloppent des nouveaux sympt\u00f4mes dans un autre organe, <strong>ou<\/strong><\/li>\n<li>Les patients qui ne peuvent pas tol\u00e9rer la diminution progressive des cortico\u00efdes, c&rsquo;est-\u00e0-dire qui commencent les cortico\u00efdes \u00e0 2,0 mg\/kg\/j, montrent une r\u00e9ponse, mais progressent avant qu&rsquo;une diminution de 50 % de la dose initiale de cortico\u00efdes ne soit atteinte.<\/li>\n<\/ul>\n<\/li>\n<li><u> <\/u>La r\u00e9sistance au ruxolitinib est d\u00e9finie comme l&rsquo;un des \u00e9l\u00e9ments suivants <u><a href=\"https:\/\/ashpublications.org\/blood\/article\/136\/17\/1903\/461710\/Refractory-acute-graft-versus-host-disease-a-new\">(Mohty M. 2020) <\/a><\/u>:\n<ul>\n<li>Progression de la GvHD par rapport \u00e0 l&rsquo;\u00e9tat initial apr\u00e8s au moins 5 jours de traitement par ruxolitinib, bas\u00e9e soit sur une augmentation objective du stade\/grade, soit sur une atteinte d&rsquo;un nouvel organe, <strong>ou<\/strong><\/li>\n<li>Absence d&rsquo;am\u00e9lioration de la GvHD (au moins une r\u00e9ponse partielle) par rapport \u00e0 l&rsquo;\u00e9tat initial, apr\u00e8s au moins 14 jours de traitement par ruxolitinib, <strong>ou<\/strong><\/li>\n<li>Perte de r\u00e9ponse, d\u00e9finie comme une aggravation objective de la GvHD d\u00e9termin\u00e9e par une augmentation du stade, du grade ou l&rsquo;atteinte d&rsquo;un nouvel organe, \u00e0 tout moment apr\u00e8s une am\u00e9lioration initiale, <strong>ou<\/strong><\/li>\n<li>Absence de r\u00e9ponse compl\u00e8te ou de tr\u00e8s bonne r\u00e9ponse partielle au 28\u00e8me jour apr\u00e8s le d\u00e9but du traitement avec ruxolitinib.<\/li>\n<\/ul>\n<\/li>\n<li>L&rsquo;intol\u00e9rance au ruxolitinib est d\u00e9finie comme des manifestations de GvHD persistant sans am\u00e9lioration chez les patients ayant pr\u00e9sent\u00e9 un effet ind\u00e9sirable de grade 3 ou plus, apparu sous traitement et attribu\u00e9 au ruxolitinib, qui ne s&rsquo;est pas r\u00e9solu dans les 7 jours suivant l&rsquo;arr\u00eat du ruxolitinib.<\/li>\n<li>aGVHD : maladie aigu\u00eb du greffon contre l&rsquo;h\u00f4te<\/li>\n<li>GI : gastro-intestinal<\/li>\n<li>MAGIC : Consortium international Mount Sinai pour la GVHD aigu\u00eb<\/li>\n<li>ORR : taux de r\u00e9ponse global<\/li>\n<li>SR : r\u00e9fractaire aux st\u00e9ro\u00efdes<\/li>\n<li>D : Jour<\/li>\n<li>M : Mois<\/li>\n<\/ul>\n[\/vc_column_text][\/toggle][\/toggles][\/vc_column][vc_column column_padding=\u00a0\u00bbno-extra-padding\u00a0\u00bb column_padding_tablet=\u00a0\u00bbinherit\u00a0\u00bb column_padding_phone=\u00a0\u00bbinherit\u00a0\u00bb column_padding_position=\u00a0\u00bball\u00a0\u00bb column_element_spacing=\u00a0\u00bbdefault\u00a0\u00bb background_color_opacity=\u00a0\u00bb1&Prime; background_hover_color_opacity=\u00a0\u00bb1&Prime; column_shadow=\u00a0\u00bbnone\u00a0\u00bb column_border_radius=\u00a0\u00bbnone\u00a0\u00bb column_link_target=\u00a0\u00bb_self\u00a0\u00bb gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb overlay_strength=\u00a0\u00bb0.3&Prime; width=\u00a0\u00bb1\/1&Prime; tablet_width_inherit=\u00a0\u00bbdefault\u00a0\u00bb tablet_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb phone_text_alignment=\u00a0\u00bbdefault\u00a0\u00bb bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb border_type=\u00a0\u00bbsimple\u00a0\u00bb column_border_width=\u00a0\u00bbnone\u00a0\u00bb column_border_style=\u00a0\u00bbsolid\u00a0\u00bb][\/vc_column][\/vc_row]\n","protected":false},"excerpt":{"rendered":"<p>[vc_row type=\u00a0\u00bbfull_width_background\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb bg_image=\u00a0\u00bb760&Prime; bg_position=\u00a0\u00bbcenter center\u00a0\u00bb background_image_loading=\u00a0\u00bbdefault\u00a0\u00bb bg_repeat=\u00a0\u00bbno-repeat\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb top_padding=\u00a0\u00bb10%\u00a0\u00bb bottom_padding=\u00a0\u00bb14%\u00a0\u00bb text_color=\u00a0\u00bblight\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb enable_gradient=\u00a0\u00bbtrue\u00a0\u00bb color_overlay=\u00a0\u00bbrgba(91,192,204,0.94)\u00a0\u00bb color_overlay_2=\u00a0\u00bb#014f90&Prime; overlay_strength=\u00a0\u00bb0.95&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb enable_shape_divider=\u00a0\u00bbtrue\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb shape_divider_height=\u00a0\u00bb190&Prime; bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb parallax_bg=\u00a0\u00bbtrue\u00a0\u00bb parallax_bg_speed=\u00a0\u00bbfast\u00a0\u00bb&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-13885","page","type-page","status-publish"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.3.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Phase 3 - MaaT Pharma<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Phase 3 - MaaT Pharma\" \/>\n<meta property=\"og:description\" content=\"[vc_row type=\u00a0\u00bbfull_width_background\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb bg_image=\u00a0\u00bb760&Prime; bg_position=\u00a0\u00bbcenter center\u00a0\u00bb background_image_loading=\u00a0\u00bbdefault\u00a0\u00bb bg_repeat=\u00a0\u00bbno-repeat\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb top_padding=\u00a0\u00bb10%\u00a0\u00bb bottom_padding=\u00a0\u00bb14%\u00a0\u00bb text_color=\u00a0\u00bblight\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb enable_gradient=\u00a0\u00bbtrue\u00a0\u00bb color_overlay=\u00a0\u00bbrgba(91,192,204,0.94)\u00a0\u00bb color_overlay_2=\u00a0\u00bb#014f90&Prime; overlay_strength=\u00a0\u00bb0.95&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb enable_shape_divider=\u00a0\u00bbtrue\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb shape_divider_height=\u00a0\u00bb190&Prime; bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb parallax_bg=\u00a0\u00bbtrue\u00a0\u00bb parallax_bg_speed=\u00a0\u00bbfast\u00a0\u00bb...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/\" \/>\n<meta property=\"og:site_name\" content=\"MaaT Pharma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-02T13:19:44+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"13 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/\",\"url\":\"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/\",\"name\":\"Phase 3 - MaaT Pharma\",\"isPartOf\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#website\"},\"datePublished\":\"2025-05-27T10:00:05+00:00\",\"dateModified\":\"2026-02-02T13:19:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/maat.swebwp.oci.eu\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Phase 3\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#website\",\"url\":\"https:\/\/maat.swebwp.oci.eu\/\",\"name\":\"MaaT Pharma\",\"description\":\"microbiota gut to fight cancer\",\"publisher\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/maat.swebwp.oci.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#organization\",\"name\":\"Maat Pharma\",\"url\":\"https:\/\/maat.swebwp.oci.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/preprod-wadesign.fr\/maat-pharma\/wp-content\/uploads\/2018\/09\/maat-logo-rvb-header.png\",\"contentUrl\":\"http:\/\/preprod-wadesign.fr\/maat-pharma\/wp-content\/uploads\/2018\/09\/maat-logo-rvb-header.png\",\"width\":150,\"height\":171,\"caption\":\"Maat Pharma\"},\"image\":{\"@id\":\"https:\/\/maat.swebwp.oci.eu\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Phase 3 - MaaT Pharma","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Phase 3 - MaaT Pharma","og_description":"[vc_row type=\u00a0\u00bbfull_width_background\u00a0\u00bb full_screen_row_position=\u00a0\u00bbmiddle\u00a0\u00bb column_margin=\u00a0\u00bbdefault\u00a0\u00bb column_direction=\u00a0\u00bbdefault\u00a0\u00bb column_direction_tablet=\u00a0\u00bbdefault\u00a0\u00bb column_direction_phone=\u00a0\u00bbdefault\u00a0\u00bb bg_image=\u00a0\u00bb760&Prime; bg_position=\u00a0\u00bbcenter center\u00a0\u00bb background_image_loading=\u00a0\u00bbdefault\u00a0\u00bb bg_repeat=\u00a0\u00bbno-repeat\u00a0\u00bb scene_position=\u00a0\u00bbcenter\u00a0\u00bb top_padding=\u00a0\u00bb10%\u00a0\u00bb bottom_padding=\u00a0\u00bb14%\u00a0\u00bb text_color=\u00a0\u00bblight\u00a0\u00bb text_align=\u00a0\u00bbleft\u00a0\u00bb row_border_radius=\u00a0\u00bbnone\u00a0\u00bb row_border_radius_applies=\u00a0\u00bbbg\u00a0\u00bb enable_gradient=\u00a0\u00bbtrue\u00a0\u00bb color_overlay=\u00a0\u00bbrgba(91,192,204,0.94)\u00a0\u00bb color_overlay_2=\u00a0\u00bb#014f90&Prime; overlay_strength=\u00a0\u00bb0.95&Prime; gradient_direction=\u00a0\u00bbleft_to_right\u00a0\u00bb enable_shape_divider=\u00a0\u00bbtrue\u00a0\u00bb shape_divider_position=\u00a0\u00bbbottom\u00a0\u00bb shape_divider_height=\u00a0\u00bb190&Prime; bg_image_animation=\u00a0\u00bbnone\u00a0\u00bb parallax_bg=\u00a0\u00bbtrue\u00a0\u00bb parallax_bg_speed=\u00a0\u00bbfast\u00a0\u00bb...","og_url":"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/","og_site_name":"MaaT Pharma","article_modified_time":"2026-02-02T13:19:44+00:00","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"13 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/","url":"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/","name":"Phase 3 - MaaT Pharma","isPartOf":{"@id":"https:\/\/maat.swebwp.oci.eu\/#website"},"datePublished":"2025-05-27T10:00:05+00:00","dateModified":"2026-02-02T13:19:44+00:00","breadcrumb":{"@id":"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/maat.swebwp.oci.eu\/fr\/phase-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/maat.swebwp.oci.eu\/fr\/"},{"@type":"ListItem","position":2,"name":"Phase 3"}]},{"@type":"WebSite","@id":"https:\/\/maat.swebwp.oci.eu\/#website","url":"https:\/\/maat.swebwp.oci.eu\/","name":"MaaT Pharma","description":"microbiota gut to fight cancer","publisher":{"@id":"https:\/\/maat.swebwp.oci.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/maat.swebwp.oci.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/maat.swebwp.oci.eu\/#organization","name":"Maat Pharma","url":"https:\/\/maat.swebwp.oci.eu\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/maat.swebwp.oci.eu\/#\/schema\/logo\/image\/","url":"http:\/\/preprod-wadesign.fr\/maat-pharma\/wp-content\/uploads\/2018\/09\/maat-logo-rvb-header.png","contentUrl":"http:\/\/preprod-wadesign.fr\/maat-pharma\/wp-content\/uploads\/2018\/09\/maat-logo-rvb-header.png","width":150,"height":171,"caption":"Maat Pharma"},"image":{"@id":"https:\/\/maat.swebwp.oci.eu\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/pages\/13885","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/comments?post=13885"}],"version-history":[{"count":5,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/pages\/13885\/revisions"}],"predecessor-version":[{"id":17320,"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/pages\/13885\/revisions\/17320"}],"wp:attachment":[{"href":"https:\/\/maat.swebwp.oci.eu\/fr\/wp-json\/wp\/v2\/media?parent=13885"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}